NIH-funded research NIH-funded research

Developing tools to predict side effects from radiation treatment

Official title: Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

Funded at Chromologic, LLC · NIH-11105742 · Data updated 2026-11-12

This study is looking to develop a test that can help predict if patients receiving radiation therapy for cancers like sarcoma and head and neck cancer might experience side effects like low white blood cell counts or lung issues, so doctors can better manage their care and improve their treatment experience.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionChromologic, LLC
NIH-funded
Lab location1 site (Monrovia, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$2,280,705
NIH project number75N93023C00016-P00003-9999-1
Project IDNIH-11105742 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing radiation treatment for sarcoma or head and neck cancer.

Less likely to help

Patients not receiving radiation therapy or those with cancers not included in the study may not benefit from this research.

What this research studies

This research focuses on creating and validating a panel of microRNAs that can predict adverse effects such as neutropenia and fibrosis in patients undergoing radiation therapy for cancers like sarcoma and head and neck cancer. The study involves collaboration with several prominent cancer centers to ensure comprehensive evaluation and aims to secure FDA approval for these predictive tools. By identifying patients at risk for these complications, the research seeks to improve patient management and treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to better prediction and management of side effects from radiation therapy, enhancing the quality of care for cancer patients.

How similar studies have gone: Previous research has shown promise in using microRNA panels for predicting treatment-related side effects, indicating a potential for success in this approach.

Where this research is happening

  • Chromologic, LLC
    Monrovia, United States
    Active

Researchers

  • Principal investigator: Nguyen, Theresa — Chromologic, LLC
  • Study coordinator: Nguyen, Theresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.